SCHEMBL4868460

SCHEMBL4868460

CN(C)C1(Cc2ccc(Cl)cc2)CCC(NC(=O)C(Cc2ccccc2)NC(=O)OC(C)(C)C)CC1

nearest known ligand 0.50

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 7/20 0.50
SCN9A Q15858 5/20 0.49
CTSS P25774 3/20 0.48
CTSK P43235 2/20 0.48
CTSL P07711 1/20 0.48
CTSB P07858 1/20 0.48
OXTR P30559 1/20 0.47
CCKAR P32238 1/20 0.46
CCKBR P32239 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4868278 0.95 SCN9A (0.53) SCN9ACTSSCTSKCTSLCTSB
SCHEMBL4861770 0.92 SCN9A (0.50) SCN9ACTSSCTSKCTSLCTSB
SCHEMBL4871968 0.89 AVPR1A (0.44) AVPR1AOXTR
SCHEMBL4864055 0.89 SCN9A (0.49) SCN9ACTSSCTSKCTSLCTSB
SCHEMBL4865061 0.87 SCN9A (0.49) SCN9ACTSSCTSKCTSLCTSB
SCHEMBL4873124 0.86 CTSS (0.55) SCN9ACTSSCTSKCTSLCTSB
SCHEMBL4867960 0.86 SCN9A (0.49) SCN9ACTSSCTSKCTSLCTSB
SCHEMBL4861830 0.85 SUV39H2 (0.43) AVPR1ASCN9AOXTR
SCHEMBL4867952 0.85 CTSS (0.51) SCN9ACTSSCTSKCTSLCTSB
SCHEMBL4868324 0.83 CTSL (0.48) SCN9ACTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751090-B1 ACID DERIVATIVES OF SUBSTITUTED CYCLOHEXYL-1,4-DIAMINES GRUENENTHAL GMBH (DE) 2014-10-08 EP claimed
US-7439394-B2 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2008-10-21 US claimed
US-20070117803-A1 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-24 US claimed
EP-1751090-A1 ACID DERIVATIVES OF SUBSTITUTED CYCLOHEXYL-1,4-DIAMINES Grünenthal GmbH (DE) 2007-02-14 EP claimed
WO-2005110973-A1 ACID DERIVATIVES OF SUBSTITUTED CYCLOHEXYL-1,4-DIAMINES Grünenthal GmbH (DE) 2005-11-24 WO claimed
EP-1751090-B1 ACID DERIVATIVES OF SUBSTITUTED CYCLOHEXYL-1,4-DIAMINES GRUENENTHAL GMBH (DE) 2014-10-08 EP disclosed
US-7439394-B2 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2008-10-21 US disclosed
US-20070117803-A1 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-24 US disclosed
EP-1751090-A1 ACID DERIVATIVES OF SUBSTITUTED CYCLOHEXYL-1,4-DIAMINES Grünenthal GmbH (DE) 2007-02-14 EP disclosed
WO-2005110973-A1 ACID DERIVATIVES OF SUBSTITUTED CYCLOHEXYL-1,4-DIAMINES Grünenthal GmbH (DE) 2005-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070117803-A1 Cyclohexyl-1,4-diamine compounds PKD1, DDC, DPYD AVPR1A 2695/4885SCN9A 1111/4885CTSS 1167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.